Risk factors analysis of atrial fibrillation after radical esophagectomy_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

TANG Jun ¹ , ZHAO Jianzhu ¹ , WANG Xiwen ¹ ,  ZHAO Jungang ¹

1. Department of Thoracic Surgery, Shengjing Hospital, China Medical University, Shenyang, 110004, P.R.China;
2. Department of Medical Oncology, Shengjing Hospital, China Medical University, Shenyang, 110004, P.R.China;

Corresponding?author：

ZHAO Jungang, Email: 65015897@qq.com

Keywords：

Radical esophagectomy; atrial fibrillation; risk factor

DOI：

10.7507/1007-4848.201708046

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analyze the risk factors of atrial fibrillation (AF) after radical esophagectomy, providing the basis for prevention and treatment of AF after radical esophagectomy. Methods We conducted a retrospective analysis of 335 patients' clinical data, who accepted laparoscopic combined thoracic or open radical esophagectomy in the same treatment group at Department of Thoracic Surgery of Shengjing Hospital of China Medical University between January 2014 and August 2016. There were 262 males and 73 females at age of 65.1 (43-78) years. Results There were 48 of 335 patients with AF within 1 week after surgery. By univariate analysis: age, gender, history of peripheral vascular disease and cardiac stents or angina pectoris, preoperative brain natriuretic peptide (BNP), preoperative left ventricular diastolic dysfunction, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion were possible risk factors. By multivariate analysis: age, gender, history of cardiac stents or angina pectoris, preoperative BNP, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion were risk factors. Conclusion The risk factors of AF after radical esophagectomy are age, gender, history of cardiac stents or angina pectoris, preoperative BNP, operation pattern, intraoperative blood transfusion and lymph nodes and pericardial adhesion. Perioperative positive intervention to above factors may reduce the incidence of postoperative AF.

Citation： TANG Jun, ZHAO Jianzhu, WANG Xiwen, ZHAO Jungang. Risk factors analysis of atrial fibrillation after radical esophagectomy. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(7): 572-576. doi: 10.7507/1007-4848.201708046 Copy

1.	Gomez-Caro A, Moradiellos MF, Ausin PF, et al. Risk factors for atrial fibrillation after thoracic surgery. Arch Bronconeumol 2006, 42:9-13.
2.	Amar D, Zhang H. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg, 2002, 95(3): 537-543.
3.	張秀錦, 李小鷹. 老年心房顫動患者抗凝治療影響因素分析. 中華保健醫學雜志, 2009, 11(3): 183-185.
4.	Amar D, Zhang H, Leung DHY, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology, 2002, 96: 352-356.
5.	Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg, 2004, 127: 779-786.
6.	Angele MK, Schwacha MG, Ayala A, et al. Effect of gender and sex hormones on immune responses following shock. Shock, 2000, 14(2): 81-90.
7.	姜衡, 魏勇, 王芹, 等. 高血壓病患者發生心房顫動的相關危險因素臨床分析.國際心血管病雜志, 2013, 40(1): 57-59.
8.	王志茹, 操敏, 李琦. 肺癌肺切除術后心律失常的相關因素分析. 中華臨床醫師雜志(電子版), 2012, 6(13): 186-187.
9.	Ojima T, Iwahashi M, Nakamori M, et al. Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today, 2014, 44: 839-847.
10.	Toufektzian L, Zisis C, Balaka C, et al. Effectiveness of brain natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing non-cardiac thoracic surgery. Interact CardioVasc Thorac Surg, 2015, 20: 654-657.
11.	Raman T, Roistacher N, Liu J, et al. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg, 2012, 143(2): 482-487.
12.	Sykes E, Karcher RE, Eisenstadt J, et al. Analytical relationships among Bolsite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol, 2005, 123(4): 584-590.
13.	Xing SY, Wang HL, Dong PS, et al. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation. Genet Mol Res, 2015, 14(2): 6953-6959.
14.	Nojiri T, Maeda H, Takeuchi Y, et al. Predictive value of B type natriuretic peptide for postoperative atrial fibrillation followinig pulmonary following pulmonary recection for lung cancer. Eur J Cardiothorac Surg, 2010, 37(4): 787-791.
15.	劉光義, 徐連芬, 王林. 電視輔助胸腔鏡手術(VATS)與開胸手術治療食管癌的療效比較. 中國現代醫生, 2015, 53(34): 46-48.
16.	孫斌, 錢寶華. 不同麻醉藥物與術中輸血對胰腺癌患者免疫功能的影響. 第二軍醫大學, 2015. 5.
17.	Moskowitz DM, Mccullouth JN, Shander A, et al. The impact of blood conservation on outcomes in caediac surgery: is it safe and effective? Ann Thorac Surg, 2010, 90(2): 451- 458.
18.	Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg, 2005, 130(2): 438-444.
19.	Gurgo AM, Ciccone AM, Dandrilli A, et al. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiol, 2008, 56(6): 581-585.
20.	王志茹, 操敏, 李琦. 肺癌肺切除術后心律失常的相關因素分析. 中華臨床醫師雜志:電子版, 2012, 6(13): 3745-3746.
21.	Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrilation: the Framingham Study. Am Heart J, 1983, 106(2): 389-396.
22.	Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factom. J Intern Med, 2001, 5(250): 382-389.
23.	閏宇博, 崔鍵, 張凱. 食管癌術后早期并發房顫的危險因素分析. 中國醫刊, 2010, 45(10): 58-61.
24.	楊建江. 食管癌術后頻發房顫原因分析及復律治療. 臨床合理用藥, 2016, 10(9): 3-6.

1. Gomez-Caro A, Moradiellos MF, Ausin PF, et al. Risk factors for atrial fibrillation after thoracic surgery. Arch Bronconeumol 2006, 42:9-13.
2. Amar D, Zhang H. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg, 2002, 95(3): 537-543.
3. 張秀錦, 李小鷹. 老年心房顫動患者抗凝治療影響因素分析. 中華保健醫學雜志, 2009, 11(3): 183-185.
4. Amar D, Zhang H, Leung DHY, et al. Older age is the strongest predictor of postoperative atrial fibrillation. Anesthesiology, 2002, 96: 352-356.
5. Vaporciyan AA, Correa AM, Rice DC, et al. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg, 2004, 127: 779-786.
6. Angele MK, Schwacha MG, Ayala A, et al. Effect of gender and sex hormones on immune responses following shock. Shock, 2000, 14(2): 81-90.
7. 姜衡, 魏勇, 王芹, 等. 高血壓病患者發生心房顫動的相關危險因素臨床分析.國際心血管病雜志, 2013, 40(1): 57-59.
8. 王志茹, 操敏, 李琦. 肺癌肺切除術后心律失常的相關因素分析. 中華臨床醫師雜志(電子版), 2012, 6(13): 186-187.
9. Ojima T, Iwahashi M, Nakamori M, et al. Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today, 2014, 44: 839-847.
10. Toufektzian L, Zisis C, Balaka C, et al. Effectiveness of brain natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing non-cardiac thoracic surgery. Interact CardioVasc Thorac Surg, 2015, 20: 654-657.
11. Raman T, Roistacher N, Liu J, et al. Preoperative left atrial dysfunction and risk of postoperative atrial fibrillation complicating thoracic surgery. J Thorac Cardiovasc Surg, 2012, 143(2): 482-487.
12. Sykes E, Karcher RE, Eisenstadt J, et al. Analytical relationships among Bolsite, Bayer, and Roche methods for BNP and NT-proBNP. Am J Clin Pathol, 2005, 123(4): 584-590.
13. Xing SY, Wang HL, Dong PS, et al. Clinical significance and levels of blood brain natriuretic peptides in patients with persistent atrial fibrillation before and after catheter ablation. Genet Mol Res, 2015, 14(2): 6953-6959.
14. Nojiri T, Maeda H, Takeuchi Y, et al. Predictive value of B type natriuretic peptide for postoperative atrial fibrillation followinig pulmonary following pulmonary recection for lung cancer. Eur J Cardiothorac Surg, 2010, 37(4): 787-791.
15. 劉光義, 徐連芬, 王林. 電視輔助胸腔鏡手術(VATS)與開胸手術治療食管癌的療效比較. 中國現代醫生, 2015, 53(34): 46-48.
16. 孫斌, 錢寶華. 不同麻醉藥物與術中輸血對胰腺癌患者免疫功能的影響. 第二軍醫大學, 2015. 5.
17. Moskowitz DM, Mccullouth JN, Shander A, et al. The impact of blood conservation on outcomes in caediac surgery: is it safe and effective? Ann Thorac Surg, 2010, 90(2): 451- 458.
18. Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg, 2005, 130(2): 438-444.
19. Gurgo AM, Ciccone AM, Dandrilli A, et al. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection. Minerva Cardioangiol, 2008, 56(6): 581-585.
20. 王志茹, 操敏, 李琦. 肺癌肺切除術后心律失常的相關因素分析. 中華臨床醫師雜志:電子版, 2012, 6(13): 3745-3746.
21. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrilation: the Framingham Study. Am Heart J, 1983, 106(2): 389-396.
22. Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factom. J Intern Med, 2001, 5(250): 382-389.
23. 閏宇博, 崔鍵, 張凱. 食管癌術后早期并發房顫的危險因素分析. 中國醫刊, 2010, 45(10): 58-61.
24. 楊建江. 食管癌術后頻發房顫原因分析及復律治療. 臨床合理用藥, 2016, 10(9): 3-6.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Risk factors analysis of atrial fibrillation after radical esophagectomy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content